Stay updated with breaking news from Edwarda Pesicka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gross Margin Expansion of 79 Basis Points Adjusted EPS Growth of Nearly Four Times with GAAP EPS Loss of $ and Adjusted EPS of $0.19 Investments Outlined at 2023 Investor Day for Long-Term Growth...
Owens & Minor impresses with Q1 results: adjusted EPS of $0.19, and sales of $2.61B (up 4% Y/Y). Patient Direct revenue reaches $638M (up 5% Y/Y). CEO Edward Pesicka highlights growth strategies and reaffirms 2024 revenue guidance of $10.5-$10.9 billion and adjusted EPS of $1.40-$1.70.
Business Delivered Strong Operating Margin Improvement in Fourth Quarter Robust Full Year Operating Cash Flow Generation Enabled Significant Debt Reduction ...
OMI's Focused Execution Drives Revenue Growth and Robust Cash Flow Generation
Owens & Minor's Q4 adjusted EPS soaring to $0.69, 4% Y/Y revenue growth to $2.66 billion, and robust Patient Direct revenue of $664 million.